Influence of antiplatelet substances on platelet-rich plasma

Masaki Yazawa, Hisao Ogata, Tatsuo Nakajima, Naohide Watanabe

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Purpose: Platelets containing a number of growth factors (platelet-derived growth factor [PDGF], transforming growth factor-β [TGF-β], etc) can be obtained in high concentrations through centrifugal separation and are used in clinical applications as platelet-rich plasma (PRP). However, only a few studies have been conducted on the growth factors present in PRP. In this study, we focused on the concentrations of growth factors in PRP and clarified the influence of using antiplatelet substances in the process of platelet concentration to improve the concentration rate of growth factors in PRP. Materials and Methods: We made platelet pellets from whole blood obtained from humans with or without some antiplatelet substances (prostaglandin E 1, aspirin, apyrase). Platelet pellets were resuspended in phosphate-buffered saline as platelet resuspensions. We measured PDGF and TGF-β1 concentrations in the samples. In measurements, we had the samples treated to release growth factors from platelets to measure accurate concentrations. Results: PDGF and TGF-β1 were concentrated to a mean of over 400% in the samples with antiplatelet substances as compared with the samples without antiplatelet substances. Conclusions: The antiplatelet substances were effective for efficiently concentrating growth factors in platelets.

Original languageEnglish
Pages (from-to)714-718
Number of pages5
JournalJournal of Oral and Maxillofacial Surgery
Volume62
Issue number6
DOIs
Publication statusPublished - 2004 Jun

Fingerprint

Platelet-Rich Plasma
Blood Platelets
Intercellular Signaling Peptides and Proteins
Platelet-Derived Growth Factor
Transforming Growth Factors
Apyrase
Prostaglandins E
Aspirin
Phosphates

ASJC Scopus subject areas

  • Dentistry(all)
  • Surgery

Cite this

Influence of antiplatelet substances on platelet-rich plasma. / Yazawa, Masaki; Ogata, Hisao; Nakajima, Tatsuo; Watanabe, Naohide.

In: Journal of Oral and Maxillofacial Surgery, Vol. 62, No. 6, 06.2004, p. 714-718.

Research output: Contribution to journalArticle

Yazawa, Masaki ; Ogata, Hisao ; Nakajima, Tatsuo ; Watanabe, Naohide. / Influence of antiplatelet substances on platelet-rich plasma. In: Journal of Oral and Maxillofacial Surgery. 2004 ; Vol. 62, No. 6. pp. 714-718.
@article{fc14db981a724046aa95725b57039142,
title = "Influence of antiplatelet substances on platelet-rich plasma",
abstract = "Purpose: Platelets containing a number of growth factors (platelet-derived growth factor [PDGF], transforming growth factor-β [TGF-β], etc) can be obtained in high concentrations through centrifugal separation and are used in clinical applications as platelet-rich plasma (PRP). However, only a few studies have been conducted on the growth factors present in PRP. In this study, we focused on the concentrations of growth factors in PRP and clarified the influence of using antiplatelet substances in the process of platelet concentration to improve the concentration rate of growth factors in PRP. Materials and Methods: We made platelet pellets from whole blood obtained from humans with or without some antiplatelet substances (prostaglandin E 1, aspirin, apyrase). Platelet pellets were resuspended in phosphate-buffered saline as platelet resuspensions. We measured PDGF and TGF-β1 concentrations in the samples. In measurements, we had the samples treated to release growth factors from platelets to measure accurate concentrations. Results: PDGF and TGF-β1 were concentrated to a mean of over 400{\%} in the samples with antiplatelet substances as compared with the samples without antiplatelet substances. Conclusions: The antiplatelet substances were effective for efficiently concentrating growth factors in platelets.",
author = "Masaki Yazawa and Hisao Ogata and Tatsuo Nakajima and Naohide Watanabe",
year = "2004",
month = "6",
doi = "10.1016/j.joms.2004.01.008",
language = "English",
volume = "62",
pages = "714--718",
journal = "Journal of Oral and Maxillofacial Surgery",
issn = "0278-2391",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Influence of antiplatelet substances on platelet-rich plasma

AU - Yazawa, Masaki

AU - Ogata, Hisao

AU - Nakajima, Tatsuo

AU - Watanabe, Naohide

PY - 2004/6

Y1 - 2004/6

N2 - Purpose: Platelets containing a number of growth factors (platelet-derived growth factor [PDGF], transforming growth factor-β [TGF-β], etc) can be obtained in high concentrations through centrifugal separation and are used in clinical applications as platelet-rich plasma (PRP). However, only a few studies have been conducted on the growth factors present in PRP. In this study, we focused on the concentrations of growth factors in PRP and clarified the influence of using antiplatelet substances in the process of platelet concentration to improve the concentration rate of growth factors in PRP. Materials and Methods: We made platelet pellets from whole blood obtained from humans with or without some antiplatelet substances (prostaglandin E 1, aspirin, apyrase). Platelet pellets were resuspended in phosphate-buffered saline as platelet resuspensions. We measured PDGF and TGF-β1 concentrations in the samples. In measurements, we had the samples treated to release growth factors from platelets to measure accurate concentrations. Results: PDGF and TGF-β1 were concentrated to a mean of over 400% in the samples with antiplatelet substances as compared with the samples without antiplatelet substances. Conclusions: The antiplatelet substances were effective for efficiently concentrating growth factors in platelets.

AB - Purpose: Platelets containing a number of growth factors (platelet-derived growth factor [PDGF], transforming growth factor-β [TGF-β], etc) can be obtained in high concentrations through centrifugal separation and are used in clinical applications as platelet-rich plasma (PRP). However, only a few studies have been conducted on the growth factors present in PRP. In this study, we focused on the concentrations of growth factors in PRP and clarified the influence of using antiplatelet substances in the process of platelet concentration to improve the concentration rate of growth factors in PRP. Materials and Methods: We made platelet pellets from whole blood obtained from humans with or without some antiplatelet substances (prostaglandin E 1, aspirin, apyrase). Platelet pellets were resuspended in phosphate-buffered saline as platelet resuspensions. We measured PDGF and TGF-β1 concentrations in the samples. In measurements, we had the samples treated to release growth factors from platelets to measure accurate concentrations. Results: PDGF and TGF-β1 were concentrated to a mean of over 400% in the samples with antiplatelet substances as compared with the samples without antiplatelet substances. Conclusions: The antiplatelet substances were effective for efficiently concentrating growth factors in platelets.

UR - http://www.scopus.com/inward/record.url?scp=2942530741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942530741&partnerID=8YFLogxK

U2 - 10.1016/j.joms.2004.01.008

DO - 10.1016/j.joms.2004.01.008

M3 - Article

C2 - 15170284

AN - SCOPUS:2942530741

VL - 62

SP - 714

EP - 718

JO - Journal of Oral and Maxillofacial Surgery

JF - Journal of Oral and Maxillofacial Surgery

SN - 0278-2391

IS - 6

ER -